km c754e-20190508095006...47 49 27 163) 16%) 12 163) 25 el a phase 3, open—label study of...

23

Upload: others

Post on 17-Jul-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 2: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 3: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 4: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 5: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 6: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 7: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 8: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 9: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 10: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 11: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 12: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 13: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 14: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 15: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 16: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 17: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 18: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 19: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 20: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 21: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 22: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire
Page 23: KM C754e-20190508095006...47 49 27 163) 16%) 12 163) 25 El A Phase 3, Open—label Study of MHOS/SHP615 in Pediatric Patients with Status Epilepticus (Convulsive) by Shire